Comparative_JJ
analysis_NN
identifies_VBZ
conserved_VBN
tumor_NN
necrosis_NN
factor_NN
receptor-associated_JJ
factor_NN
3_CD
binding_NN
sites_NNS
in_IN
the_DT
human_JJ
and_CC
simian_JJ
Epstein-Barr_JJ
virus_NN
oncogene_NN
LMP1_NN
._.

Nonhuman_JJ
primates_NNS
are_VBP
naturally_RB
infected_JJ
with_IN
a_DT
B-lymphotropic_JJ
herpesvirus_NN
closely_RB
related_JJ
to_TO
Epstein-Barr_JJ
virus_NN
-LRB-_-LRB-
EBV_NN
-RRB-_-RRB-
._.

These_DT
simian_JJ
EBV_NN
share_VBP
considerable_JJ
genetic_JJ
,_,
biologic_JJ
,_,
and_CC
epidemiologic_JJ
features_NNS
with_IN
human_JJ
EBV_NN
,_,
including_VBG
virus-induced_JJ
tumorigenesis_NN
._.

However_RB
,_,
latent_JJ
,_,
transformation-associated_JJ
viral_JJ
genes_NNS
demonstrate_VBP
marked_JJ
sequence_NN
divergence_NN
among_IN
species_NNS
despite_IN
the_DT
conserved_VBN
functions_NNS
._.

We_PRP
have_VBP
cloned_VBN
the_DT
latent_JJ
membrane_NN
protein_NN
1_CD
-LRB-_-LRB-
LMP1_NN
-RRB-_-RRB-
homologs_NNS
from_IN
the_DT
simian_JJ
EBV_NN
naturally_RB
infecting_VBG
baboons_NNS
-LRB-_-LRB-
cercopithicine_NN
herpesvirus_NN
12_CD
,_,
herpesvirus_NN
papio_NN
-RRB-_-RRB-
and_CC
rhesus_NN
monkeys_NNS
-LRB-_-LRB-
cercopithicine_NN
herpesvirus_NN
15_CD
-RRB-_-RRB-
for_IN
a_DT
comparative_JJ
study_NN
with_IN
the_DT
human_JJ
EBV_NN
oncogene_NN
._.

The_DT
transmembrane_JJ
domains_NNS
are_VBP
well_RB
conserved_VBN
,_,
but_CC
there_EX
is_VBZ
striking_JJ
sequence_NN
divergence_NN
of_IN
the_DT
carboxy-terminal_JJ
cytoplasmic_JJ
domain_NN
essential_JJ
for_IN
B-cell_NN
immortalization_NN
and_CC
interaction_NN
with_IN
the_DT
tumor_NN
necrosis_NN
factor_NN
receptor_NN
signaling_NN
pathway_NN
._.

Nevertheless_RB
,_,
the_DT
simian_JJ
EBV_NN
LMP1s_NNS
retain_VBP
most_JJS
functions_NNS
in_IN
common_JJ
with_IN
EBV_NN
LMP1_NN
,_,
including_VBG
the_DT
ability_NN
to_TO
induce_VB
NF_NN
-_:
-LRB-_-LRB-
kappa_NN
-RRB-_-RRB-
B_NN
activity_NN
in_IN
human_JJ
cells_NNS
,_,
to_TO
bind_VB
the_DT
tumor_NN
necrosis_NN
factor-associated_JJ
factor_NN
3_CD
-LRB-_-LRB-
TRAF3_NN
-RRB-_-RRB-
in_FW
vitro_FW
,_,
and_CC
to_TO
induce_VB
expression_NN
of_IN
tumor_NN
necrosis_NN
factor-responsive_JJ
genes_NNS
,_,
such_JJ
as_IN
ICAM1_NN
,_,
in_IN
human_JJ
B_NN
lymphocytes_NNS
._.

Multiple_JJ
TRAF3_NN
binding_NN
sites_NNS
containing_VBG
a_DT
PXQXT\/S_NN
core_NN
sequence_NN
can_MD
be_VB
identified_VBN
in_IN
the_DT
simian_JJ
EBV_NN
LMP1s_NNS
by_IN
an_DT
in_FW
vitro_FW
binding_NN
assay_NN
._.

A_DT
PXQXT\/S-containing_JJ
sequence_NN
is_VBZ
also_RB
present_JJ
in_IN
the_DT
cytoplasmic_JJ
domain_NN
of_IN
the_DT
Hodgkin_NN
's_POS
disease_NN
marker_NN
,_,
CD30_NN
,_,
and_CC
binds_VBZ
TRAF3_NN
in_FW
vitro_FW
._.

The_DT
last_JJ
13_CD
amino_NN
acids_NNS
containing_VBG
a_DT
PXQXT\/S_NN
sequence_NN
are_VBP
highly_RB
conserved_VBN
in_IN
human_JJ
and_CC
simian_JJ
EBV_NN
LMP1_NN
but_CC
do_VBP
not_RB
bind_VB
TRAF3_NN
,_,
suggesting_VBG
a_DT
distinct_JJ
role_NN
for_IN
this_DT
conserved_VBN
region_NN
of_IN
LMP1_NN
._.

The_DT
conserved_VBN
TRAF3_NN
binding_NN
sites_NNS
in_IN
LMP1_NN
and_CC
the_DT
CD30_NN
Hodgkin_NN
's_POS
disease_NN
marker_NN
provides_VBZ
further_JJ
evidence_NN
that_IN
a_DT
TRAF3-mediated_JJ
signal_NN
transduction_NN
pathway_NN
may_MD
be_VB
important_JJ
in_IN
malignant_JJ
transformation_NN
._.

